Literature DB >> 20811370

Deal watch: Metabolex and Sanofi-Aventis partner on GPCR agonists for type 2 diabetes.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20811370     DOI： 10.1038/nrd3255

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

Review 1.  Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.

Authors:  Bo Ahrén
Journal:  Nat Rev Drug Discov       Date:  2009-04-14       Impact factor: 84.694
  1 in total
  1 in total

Review 1.  Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease.

Authors:  Jianan Zhao; Yu Zhao; Yiyang Hu; Jinghua Peng
Journal:  Cell Mol Biol Lett       Date:  2021-07-07       Impact factor: 5.787
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.